Laboratorios Farmaceuticos Rovi (ES:ROVI) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Laboratorios Farmacéuticos Rovi, S.A. has announced a modification to the securities and cash balances of its Liquidity Contract with Bestinver SV, S.A. Following the adjustment, the securities account will contain 6,000 shares, and the cash balance will stand at 570,000 euros.
For further insights into ES:ROVI stock, check out TipRanks’ Stock Analysis page.